Gilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show
(By Matthew Herper for STAT) Remdesivir, the drug developed as a treatment for Covid-19 by Gilead Sciences, helped patients with
Read More(By Matthew Herper for STAT) Remdesivir, the drug developed as a treatment for Covid-19 by Gilead Sciences, helped patients with
Read More(By Michelle Andrews for Kaiser Health News) The economic upheaval and social disruption caused by the coronavirus pandemic have upended
Read MoreCigna is eliminating cost-sharing for all primary care, specialty are and behavioral health care in office or telehealth visits for
Read More(By Katie Adams for Becker’s Hospital Review) Delta Dental of Tennessee is providing 24 safety-net dental practices with $1.1 million
Read More(Source – www.blogs.va.gov) With continued advances in technology, apps for smartphones and other mobile devices can provide an ideal way
Read MoreThe IRS has increased the 2021 deductible contributions limits for health savings account by $50 for individuals and $100 for
Read More(By Anuja Vaidya for Becker’s Hospital Review) Though minutes can make all the difference in the treatment of people having
Read More(By Jackie Drees for Becker’s Hospital Review) The Rhode Island Senate Health and Human Services Committee on May 27 advanced a
Read More(By Karen Pollitz, Matthew Rae, Cynthia Cox, Rabah Kamal, Rachel Fehr, and Greg Young For Kaiser Family Foundation) The COVID-19 pandemic has
Read MoreLast year when you were picking your 2020 employer health insurance policy you couldn’t have planned for the coronavirus pandemic.
Read More